These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9213806)

  • 1. [There is no evidence of more symptoms with mefloquine than with other drugs in malaria prophylaxis].
    de Beer PA
    Ned Tijdschr Geneeskd; 1997 Apr; 141(16):795. PubMed ID: 9213806
    [No Abstract]   [Full Text] [Related]  

  • 2. [Not more symptoms with mefloquine use than with other drugs in malaria prophylaxis].
    Wolters BA; Bosje T; Luinstra-Passchier MJ
    Ned Tijdschr Geneeskd; 1997 Feb; 141(7):331-4. PubMed ID: 9132607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A severe adverse reaction to mefloquine and chloroquine prophylaxis.
    Lysack JT; Lysack CL; Kvern BL
    Aust Fam Physician; 1998 Dec; 27(12):1119-20. PubMed ID: 9919736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malaria chemoprophylaxis: tolerance and compliance with mefloquine and proguanil/chloroquine combination in French tourists].
    Carme B; Péguet C; Nevez G
    Bull Soc Pathol Exot; 1997; 90(4):273-6. PubMed ID: 9479468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Many travellers suffer of side-effects of malaria prophylaxis].
    Rietz G; Petersson H; Odenholt I
    Lakartidningen; 2002 Jun; 99(26-27):2939-44. PubMed ID: 12170684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [There is no evidence of more symptoms with mefloquine than with other drugs in malaria prophylaxis].
    Cobelens FG; van Thiel PP
    Ned Tijdschr Geneeskd; 1997 Apr; 141(16):794-5; author reply 796. PubMed ID: 9213805
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adverse effects associated with antimalarial chemoprophylaxis].
    Corominas N; Gascón J; Mejías T; Caparrós F; Quintó L; Codina C; Ribas J; Corachán M
    Med Clin (Barc); 1997 May; 108(20):772-5. PubMed ID: 9265081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: a focus on neuropsychiatric adverse events.
    van Riemsdijk MM; Sturkenboom MC; Ditters JM; Ligthelm RJ; Overbosch D; Stricker BH
    Clin Pharmacol Ther; 2002 Sep; 72(3):294-301. PubMed ID: 12235450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of antimalarial drugs.
    Croft AM; Beer MD; Herxheimer A
    N Engl J Med; 2005 Jul; 353(4):420-2; author reply 420-2. PubMed ID: 16050052
    [No Abstract]   [Full Text] [Related]  

  • 11. [Malaria prophylaxis for long-term travellers and expatriates].
    Kurtzhals JA; Vestergaard LS
    Ugeskr Laeger; 2005 Oct; 167(42):3988-92. PubMed ID: 16232398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Not more symptoms with mefloquine use than with other drugs in malaria prophylaxis].
    Kok PW; Puls FT; Zonderland HD
    Ned Tijdschr Geneeskd; 1997 May; 141(18):898. PubMed ID: 9273455
    [No Abstract]   [Full Text] [Related]  

  • 13. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
    Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mefloquine-induced pneumonitis.
    Soentjens P; Delanote M; Van Gompel A
    J Travel Med; 2006; 13(3):172-4. PubMed ID: 16706949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of mood profiles during malaria chemoprophylaxis: a randomized, double-blind, four-arm study.
    Schlagenhauf P; Johnson R; Schwartz E; Nothdurft HD; Steffen R
    J Travel Med; 2009; 16(1):42-5. PubMed ID: 19192127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis.
    Alisky JM; Chertkova EL; Iczkowski KA
    Med Hypotheses; 2006; 67(5):1090-4. PubMed ID: 16843615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lariam's legacy.
    Consum Rep; 2002 Mar; 67(3):60-1. PubMed ID: 11863012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Italian army standpoint on malaria chemoprophylaxis.
    Peragallo MS
    Med Trop (Mars); 2001; 61(1):59-62. PubMed ID: 11584658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paranoid psychosis related to mefloquine antimalarial prophylaxis.
    Fuller SJ; Naraqi S; Gilessi G
    P N G Med J; 2002; 45(3-4):219-21. PubMed ID: 12968793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuropsychiatric side effects of malarial prophylaxis with mefloquine (Lariam)].
    Minei-Rachmilewitz T
    Harefuah; 1999 Jul; 137(1-2):25-7, 87. PubMed ID: 10959270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.